Premium
CLINICAL ANALYSIS OF AFATINIB IN EGFR‐TYROSINE KINASE INHIBITOR NAÏVE PATIENTS WITH NON‐SMALL CELL LUNG CANCER HABORING EGFR MUTATIONS
Publication year - 2017
Publication title -
respirology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.857
H-Index - 85
eISSN - 1440-1843
pISSN - 1323-7799
DOI - 10.1111/resp.13207_77
Subject(s) - afatinib , medicine , lung cancer , tyrosine kinase inhibitor , tyrosine kinase , oncology , erlotinib , cancer research , gefitinib , cancer , epidermal growth factor receptor , receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom